Optimized method development and validation for determining donepezil in rat plasma: A liquid-liquid extraction, LC-MS/MS, and design of experiments approach
PLOS ONE · 06.09.2024 · 19 (9) · e0309802
DOI: 10.1371/journal.pone.0309802 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift PLOS ONE, online erschienen am 06.09.2024. Verfasst von Ye Bin Shin und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Dankook University, Cheonan, Chungnam, South Korea. Hauptthemen laut MEDLINE: Donepezil, Tandem Mass Spectrometry, Liquid-Liquid Extraction, Piperidines. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Donepezil (DPZ), a piperidine-based reversible cholinesterase inhibitor, finds extensive use in treating Alzheimer’s disease (AD). Originally designed as an oral formulation, DPZ encounters drawbacks such as a brief duration of action and reduced treatment effectiveness in elderly patients with memory impairment or difficulty swallowing medications. To address these issues and improve patient compliance, researchers are actively exploring alternative DPZ formulations. Consequently, reliable methods are necessary to quantitate DPZ in biological samples for in vivo assessment. Therefore, we propose an efficient, sensitive, wide-dynamic, and cost-effective method for quantitating DPZ in rat plasma. Our method employs liquid-liquid extraction (LLE) followed by liquid chromatography and tandem mass spectrometry, enabling in vivo evaluation of novel DPZ formulations. Notably, our method requires only 20 μL of rat plasma and employs icopezil as the internal standard—a cost-effective compound with chemical similarity to DPZ. We meticulously optimized LLE conditions, taking into account factor interactions through design of experiments (DOE). Our rapid and straightforward extraction and purification involved using 500 μL of pure methyl tert -butyl ether to extract DPZ from the sample within five minutes. The dynamic range of the method extends from 0.5 ng/mL to 1,000 ng/mL, demonstrating excellent sensitivity and suitability for pharmacokinetic studies across diverse DPZ formulations. Following the FDA guidelines, we rigorously validated the developed method, evaluating selectivity, linearity (with a coefficient of determination ≥0.9999), accuracy (ranging from 96.0% to 109.6%), precision (≤13.9%), matrix effect (92.2% to 103.8%), recovery (98.5% to 106.8%), the lower limit of quantitation (0.5 ng/mL), and stability. Finally, we effectively employed the validated method for the long-term pharmacokinetic assessment of a DPZ formulation. We expect that this approach will make a substantial contribution to the advancement of new DPZ formulations, ultimately benefiting individuals afflicted by AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, Dankook University, Cheonan, Chungnam, South Korea.
- Department of Pharmaceutical Engineering, Dankook University, Cheonan, Chungnam, South Korea.
ORCID-Profile: Jin Hwan Kim, Yong Seok Choi
Zitieren
APA
Shin, Y. B., Kim, J. H., Kwon, M. K., Myung, J. H., Lee, D. G., Jin, S. G., Kang, M. J., & Choi, Y. S. (2024). Optimized method development and validation for determining donepezil in rat plasma: A liquid-liquid extraction, LC-MS/MS, and design of experiments approach. PLOS ONE, 19(9), e0309802. https://doi.org/10.1371/journal.pone.0309802
Vancouver
Shin YB, Kim JH, Kwon MK, Myung JH, Lee DG, Jin SG, et al. Optimized method development and validation for determining donepezil in rat plasma: A liquid-liquid extraction, LC-MS/MS, and design of experiments approach. PLOS ONE. 2024;19(9):e0309802. doi:10.1371/journal.pone.0309802
BibTeX
@article{Shin2024,
author = {Shin, Ye Bin and Kim, Jin Hwan and Kwon, Min Kyeong and Myung, Jin Hyuk and Lee, Dong Geon and Jin, Sung Giu and Kang, Myung Joo and Choi, Yong Seok},
title = {Optimized method development and validation for determining donepezil in rat plasma: A liquid-liquid extraction, LC-MS/MS, and design of experiments approach},
journal = {PLOS ONE},
year = {2024},
volume = {19},
number = {9},
pages = {e0309802},
doi = {10.1371/journal.pone.0309802}
}
EUVIMED